Clinical outcome analysis of different first‑ and second‑generation EGFR‑tyrosine kinase inhibitors in untreated patients with EGFR‑mutated non‑small cell lung cancer with baseline brain metastasis.

对未经治疗的 EGFR 突变非小细胞肺癌伴基线脑转移患者进行不同的第一代和第二代 EGFR 酪氨酸激酶抑制剂的临床结果分析